These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35856178)

  • 1. The effect of BNT162b2 SARS-CoV-2 mRNA vaccine on menstrual cycle symptoms in healthy women.
    Lessans N; Rottenstreich A; Stern S; Gilan A; Saar TD; Porat S; Dior UP
    Int J Gynaecol Obstet; 2023 Jan; 160(1):313-318. PubMed ID: 35856178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of SARS-CoV-2 BNT162b2 vaccine on the symptoms of women with endometriosis.
    Gilan A; Laster-Haim S; Rottenstreich A; Porat S; Lessans N; Saar TD; Dior UP
    Arch Gynecol Obstet; 2023 Jan; 307(1):121-127. PubMed ID: 36098831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between SARS-CoV-2 vaccination and healthcare contacts for menstrual disturbance and bleeding in women before and after menopause: nationwide, register based cohort study.
    Ljung R; Xu Y; Sundström A; Leach S; Hallberg E; Bygdell M; Larsson M; Arthurson V; Gisslén M; Gedeborg R; Nyberg F
    BMJ; 2023 May; 381():e074778. PubMed ID: 37137493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
    Oda Y; Kumagai Y; Kanai M; Iwama Y; Okura I; Minamida T; Yagi Y; Kurosawa T; Greener B; Zhang Y; Walson JL
    Lancet Infect Dis; 2024 Apr; 24(4):351-360. PubMed ID: 38141632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual cycle changes: A cross-sectional study of Saudi females following SARS-CoV-2 infection.
    Abdel-Moneim YAS; Alghamdi HY; Alrashed AM; Jawhari AM; Bukhari SMM; Bukhari NMM; Abdel-Moneim AS
    PLoS One; 2022; 17(12):e0279408. PubMed ID: 36538566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
    Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of the association between SARS-CoV-2 infection and COVID-19 vaccination with changes in usual menstrual cycle characteristics.
    Wang S; Mortazavi J; Hart JE; Hankins JA; Katuska LM; Farland LV; Gaskins AJ; Wang YX; Tamimi RM; Terry KL; Rich-Edwards JW; Missmer SA; Chavarro JE
    Am J Obstet Gynecol; 2022 Nov; 227(5):739.e1-739.e11. PubMed ID: 35841938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of three doses of the BNT162b2 mRNA vaccine with abnormal bleeding and an irregular menstrual cycle among premenopausal females: A single institute observation study.
    Namiki T; Komine-Aizawa S; Takada K; Takano C; Trinh QD; Hayakawa S
    J Obstet Gynaecol Res; 2022 Nov; 48(11):2903-2910. PubMed ID: 36319205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of COVID-19 Vaccination on Menstrual Cycle Patterns of Reproductive-age Women: A Multi-centric Observational Study.
    Kumar N; Gangane N; Mohapatra I; Rukadikar C; Sharmila V; Pushpalatha K; Eerike M; Santhoshi G; Samantaray SR; Seth S; Trigunait P; Reddy NJ; Patel S; Rani S; Mishra R; Negi K
    Curr Drug Res Rev; 2024; 16(2):237-248. PubMed ID: 37291775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records.
    Niesen MJM; Pawlowski C; O'Horo JC; Challener DW; Silvert E; Donadio G; Lenehan PJ; Virk A; Swift MD; Speicher LL; Gordon JE; Geyer HL; Halamka JD; Venkatakrishnan AJ; Soundararajan V; Badley AD
    JAMA Netw Open; 2022 Apr; 5(4):e227038. PubMed ID: 35420661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenstrual and menstrual changes reported after COVID-19 vaccination: The EVA project.
    Baena-García L; Aparicio VA; Molina-López A; Aranda P; Cámara-Roca L; Ocón-Hernández O
    Womens Health (Lond); 2022; 18():17455057221112237. PubMed ID: 35833668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of menstrual symptoms after Coronavirus disease 2019 vaccination in women with endometriosis.
    Martínez-Zamora MÁ; Feixas G; Gracia M; Rius M; Quintas L; de Guirior C; Carmona F
    Womens Health (Lond); 2023; 19():17455057231176751. PubMed ID: 37282979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccination and changes in the menstrual cycle among vaccinated persons.
    Farland LV; Khan SM; Shilen A; Heslin KM; Ishimwe P; Allen AM; Herbst-Kralovetz MM; Mahnert ND; Pogreba-Brown K; Ernst KC; Jacobs ET
    Fertil Steril; 2023 Mar; 119(3):392-400. PubMed ID: 36539055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.
    Patone M; Mei XW; Handunnetthi L; Dixon S; Zaccardi F; Shankar-Hari M; Watkinson P; Khunti K; Harnden A; Coupland CAC; Channon KM; Mills NL; Sheikh A; Hippisley-Cox J
    Circulation; 2022 Sep; 146(10):743-754. PubMed ID: 35993236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of and risk factors for self-reported menstrual changes following COVID-19 vaccination: a Danish cohort study.
    Bisgaard Jensen C; Bech BH; Hansen SN; Rask CU; Fink P; Nielsen H; Meinertz Dantoft T; Thysen SM; Rytter D
    Hum Reprod; 2023 Sep; 38(9):1825-1834. PubMed ID: 37437904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysmenorrhea, intermenstrual bleeding, menstrual flow volume changes, and irregularities following COVID-19 vaccination and the association with vaccine skepticism: A retrospective observational study.
    Khan GA; Althubaiti A; Alshrif A; Alsayed Z; Jifree H
    Womens Health (Lond); 2023; 19():17455057231210094. PubMed ID: 37966030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    Hippisley-Cox J; Patone M; Mei XW; Saatci D; Dixon S; Khunti K; Zaccardi F; Watkinson P; Shankar-Hari M; Doidge J; Harrison DA; Griffin SJ; Sheikh A; Coupland CAC
    BMJ; 2021 Aug; 374():n1931. PubMed ID: 34446426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.